Published in Genes Chromosomes Cancer on November 10, 2011
Identifying potential cancer driver genes by genomic data integration. Sci Rep (2013) 0.95
High RAB25 expression is associated with good clinical outcome in patients with locally advanced head and neck squamous cell carcinoma. Cancer Med (2013) 0.82
Potential therapeutic targets for oral cancer: ADM, TP53, EGFR, LYN, CTLA4, SKIL, CTGF, CD70. PLoS One (2014) 0.82
An integrated approach to uncover driver genes in breast cancer methylation genomes. PLoS One (2013) 0.81
Downregulation of keratin 76 expression during oral carcinogenesis of human, hamster and mouse. PLoS One (2013) 0.79
Largescale Transcriptomics Analysis Suggests Over-Expression of BGH3, MMP9 and PDIA3 in Oral Squamous Cell Carcinoma. PLoS One (2016) 0.77
Phylogenetic analysis of multiple FISH markers in oral tongue squamous cell carcinoma suggests that a diverse distribution of copy number changes is associated with poor prognosis. Int J Cancer (2015) 0.76
A systematic comparison of copy number alterations in four types of female cancer. BMC Cancer (2016) 0.75
Chromosomal Alterations and Gene Expression Changes Associated with the Progression of Leukoplakia to Advanced Gingivobuccal Cancer. Transl Oncol (2017) 0.75
Bioconductor: open software development for computational biology and bioinformatics. Genome Biol (2004) 143.19
Hallmarks of cancer: the next generation. Cell (2011) 140.01
Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol (2004) 101.91
Immunity, inflammation, and cancer. Cell (2010) 28.27
Chromosome aberrations in solid tumors. Nat Genet (2003) 7.01
Impact of DNA amplification on gene expression patterns in breast cancer. Cancer Res (2002) 5.99
A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications. Cancer Res (2003) 5.04
An integrated approach to uncover drivers of cancer. Cell (2010) 4.53
A census of amplified and overexpressed human cancer genes. Nat Rev Cancer (2010) 4.47
Cytokines in cancer pathogenesis and cancer therapy. Nat Rev Cancer (2004) 4.43
Integrated analysis of homozygous deletions, focal amplifications, and sequence alterations in breast and colorectal cancers. Proc Natl Acad Sci U S A (2008) 4.13
The inhibitors of apoptosis (IAPs) as cancer targets. Apoptosis (2007) 3.16
Rare amplicons implicate frequent deregulation of cell fate specification pathways in oral squamous cell carcinoma. Oncogene (2005) 2.99
Posttranscriptional downregulation of c-IAP2 by the ubiquitin protein ligase c-IAP1 in vivo. Mol Cell Biol (2005) 2.57
Alert for an epidemic of oral cancer due to use of the betel quid substitutes gutkha and pan masala: a review of agents and causative mechanisms. Mutagenesis (2004) 2.17
Gene expression profiles identify epithelial-to-mesenchymal transition and activation of nuclear factor-kappaB signaling as characteristics of a high-risk head and neck squamous cell carcinoma. Cancer Res (2006) 2.13
A gene signature predictive for outcome in advanced ovarian cancer identifies a survival factor: microfibril-associated glycoprotein 2. Cancer Cell (2009) 2.13
Transcriptomic dissection of tongue squamous cell carcinoma. BMC Genomics (2008) 2.09
Glutathione peroxidase 3, deleted or methylated in prostate cancer, suppresses prostate cancer growth and metastasis. Cancer Res (2007) 1.74
The inhibitor of apoptosis proteins as therapeutic targets in cancer. Clin Cancer Res (2007) 1.63
Gene expression profiling identifies genes predictive of oral squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev (2008) 1.60
Comprehensive genome and transcriptome analysis of the 11q13 amplicon in human oral cancer and synteny to the 7F5 amplicon in murine oral carcinoma. Genes Chromosomes Cancer (2006) 1.49
Genomewide mRNA profiling of esophageal squamous cell carcinoma for identification of cancer biomarkers. Cancer Biol Ther (2009) 1.45
Genetic differences detected by comparative genomic hybridization in head and neck squamous cell carcinomas from different tumor sites: construction of oncogenetic trees for tumor progression. Genes Chromosomes Cancer (2002) 1.45
Global expression-based classification of lymph node metastasis and extracapsular spread of oral tongue squamous cell carcinoma. Neoplasia (2006) 1.44
Role of hypoxia inducible factor-1 alpha in modulation of apoptosis resistance. Oncogene (2006) 1.42
Cancer-testis antigen lymphocyte antigen 6 complex locus K is a serologic biomarker and a therapeutic target for lung and esophageal carcinomas. Cancer Res (2007) 1.42
Identification of potential biomarkers of lymph node metastasis in oral squamous cell carcinoma by cDNA microarray analysis. Int J Cancer (2003) 1.41
Aberrant expression of RAB1A in human tongue cancer. Br J Cancer (2005) 1.40
ANO1 amplification and expression in HNSCC with a high propensity for future distant metastasis and its functions in HNSCC cell lines. Br J Cancer (2010) 1.38
High-resolution copy number and gene expression microarray analyses of head and neck squamous cell carcinoma cell lines of tongue and larynx. Genes Chromosomes Cancer (2008) 1.30
Oral tongue cancer gene expression profiling: Identification of novel potential prognosticators by oligonucleotide microarray analysis. BMC Cancer (2009) 1.30
Inhibition of arachidonic acid metabolism and its implication on cell proliferation and tumour-angiogenesis. Int Immunopharmacol (2009) 1.26
Identification of target genes in laryngeal squamous cell carcinoma by high-resolution copy number and gene expression microarray analyses. Oncogene (2006) 1.26
Gene dosage, expression, and ontology analysis identifies driver genes in the carcinogenesis and chemoradioresistance of cervical cancer. PLoS Genet (2009) 1.19
Activation of MAP kinase signaling through ERK5 but not ERK1 expression is associated with lymph node metastases in oral squamous cell carcinoma (OSCC). Neoplasia (2008) 1.17
Characterization of the human Ly-6 antigens, the newly annotated member Ly-6K included, as molecular markers for head-and-neck squamous cell carcinoma. Int J Cancer (2003) 1.12
Integrative analysis of DNA copy number and gene expression in metastatic oral squamous cell carcinoma identifies genes associated with poor survival. Mol Cancer (2010) 1.09
Microfibril-associated glycoprotein-2 interacts with fibrillin-1 and fibrillin-2 suggesting a role for MAGP-2 in elastic fiber assembly. J Biol Chem (2002) 1.08
Chromosome 8q24-Associated Cancers and MYC. Genes Cancer (2010) 1.07
Down-regulation of cIAP2 enhances 5-FU sensitivity through the apoptotic pathway in human colon cancer cells. Cancer Sci (2009) 1.04
cIAP2 upregulated by E6 oncoprotein via epidermal growth factor receptor/phosphatidylinositol 3-kinase/AKT pathway confers resistance to cisplatin in human papillomavirus 16/18-infected lung cancer. Clin Cancer Res (2010) 1.03
Expression and prognostic significance of the inhibitor of apoptosis protein (IAP) family and its antagonists in chronic lymphocytic leukaemia. Eur J Cancer (2010) 1.03
A genetic expression profile associated with oral cancer identifies a group of patients at high risk of poor survival. Clin Cancer Res (2009) 1.00
Recurrent overexpression of c-IAP2 in EBV-associated nasopharyngeal carcinomas: critical role in resistance to Toll-like receptor 3-mediated apoptosis. Neoplasia (2008) 1.00
Oral cancer overexpressed 1 (ORAOV1) regulates cell cycle and apoptosis in cervical cancer HeLa cells. Mol Cancer (2010) 0.99
Maintenance of head and neck tumor gene expression profiles upon lymph node metastasis. Cancer Res (2006) 0.99
Potential markers of tongue tumor progression selected by cDNA microarray. Int J Immunopathol Pharmacol (2005) 0.97
DNA amplification and expression of FADD in oral squamous cell carcinoma. J Oral Pathol Med (2009) 0.97
Construction of oncogenetic tree models reveals multiple pathways of oral cancer progression. Int J Cancer (2009) 0.97
Oral cancer overexpressed 1 (ORAOV1): a regulator for the cell growth and tumor angiogenesis in oral squamous cell carcinoma. Int J Cancer (2008) 0.97
Amplification and overexpression of PPFIA1, a putative 11q13 invasion suppressor gene, in head and neck squamous cell carcinoma. Genes Chromosomes Cancer (2008) 0.95
Advanced squamous cell carcinoma of lower gingivobuccal complex: patterns of spread and failure. Head Neck (2005) 0.93
Genomic profiling of advanced-stage oral cancers reveals chromosome 11q alterations as markers of poor clinical outcome. PLoS One (2011) 0.92
Gene expression profiling in squamous cell carcinoma of the oral cavity shows abnormalities in several signaling pathways. Laryngoscope (2005) 0.92
MYC gene amplification reveals clinical association with head and neck squamous cell carcinoma in Indian patients. J Oral Pathol Med (2009) 0.89
Molecular expression of Ly6k, a putative glycosylphosphatidyl-inositol-anchored membrane protein on the mouse testicular germ cells. Biochem Biophys Res Commun (2010) 0.87
Evaluating annotations of an Agilent expression chip suggests that many features cannot be interpreted. BMC Genomics (2009) 0.85
T-lymphocyte maturation-associated protein gene as a candidate metastasis suppressor for head and neck squamous cell carcinomas. Cancer Sci (2009) 0.83
ROCR: visualizing classifier performance in R. Bioinformatics (2005) 19.60
HPV screening for cervical cancer in rural India. N Engl J Med (2009) 14.13
Comparative lesion sequencing provides insights into tumor evolution. Proc Natl Acad Sci U S A (2008) 10.52
STAT3 mutations in the hyper-IgE syndrome. N Engl J Med (2007) 8.99
Database indexing for production MegaBLAST searches. Bioinformatics (2008) 8.73
Protein database searches using compositionally adjusted substitution matrices. FEBS J (2005) 8.14
Inflammatory bowel disease and mutations affecting the interleukin-10 receptor. N Engl J Med (2009) 7.53
A fast and symmetric DUST implementation to mask low-complexity DNA sequences. J Comput Biol (2006) 7.38
Clinical and biological implications of driver mutations in myelodysplastic syndromes. Blood (2013) 6.50
WindowMasker: window-based masker for sequenced genomes. Bioinformatics (2005) 5.91
Viral population estimation using pyrosequencing. PLoS Comput Biol (2008) 5.89
A homozygous CARD9 mutation in a family with susceptibility to fungal infections. N Engl J Med (2009) 5.20
Elective versus Therapeutic Neck Dissection in Node-Negative Oral Cancer. N Engl J Med (2015) 4.95
Initial sequence and comparative analysis of the cat genome. Genome Res (2007) 4.67
Error correction of next-generation sequencing data and reliable estimation of HIV quasispecies. Nucleic Acids Res (2010) 3.31
Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency. Nat Immunol (2003) 3.16
HAX1 deficiency causes autosomal recessive severe congenital neutropenia (Kostmann disease). Nat Genet (2006) 3.03
Composition-based statistics and translated nucleotide searches: improving the TBLASTN module of BLAST. BMC Biol (2006) 2.90
Domain enhanced lookup time accelerated BLAST. Biol Direct (2012) 2.87
A novel human primary immunodeficiency syndrome caused by deficiency of the endosomal adaptor protein p14. Nat Med (2006) 2.85
ShoRAH: estimating the genetic diversity of a mixed sample from next-generation sequencing data. BMC Bioinformatics (2011) 2.60
Predicting HIV coreceptor usage on the basis of genetic and clinical covariates. Antivir Ther (2007) 2.49
Deep sequencing of a genetically heterogeneous sample: local haplotype reconstruction and read error correction. J Comput Biol (2010) 2.37
A syndrome with congenital neutropenia and mutations in G6PC3. N Engl J Med (2009) 2.30
Reliable detection of subclonal single-nucleotide variants in tumour cell populations. Nat Commun (2012) 2.06
Sarcomatoid (spindle cell) carcinoma of the head and neck mucosal region: a clinicopathologic review of 103 cases from a tertiary referral cancer centre. Head Neck Pathol (2010) 2.02
Deleterious mutations in LRBA are associated with a syndrome of immune deficiency and autoimmunity. Am J Hum Genet (2012) 1.94
24 hours in the life of HIV-1 in a T cell line. PLoS Pathog (2013) 1.89
The phenotype of human STK4 deficiency. Blood (2012) 1.84
Retrieval accuracy, statistical significance and compositional similarity in protein sequence database searches. Nucleic Acids Res (2006) 1.81
Control of plant organ size by KLUH/CYP78A5-dependent intercellular signaling. Dev Cell (2007) 1.80
A cluster randomized controlled trial of visual, cytology and human papillomavirus screening for cancer of the cervix in rural India. Int J Cancer (2005) 1.78
PSI-BLAST pseudocounts and the minimum description length principle. Nucleic Acids Res (2008) 1.68
Polycomb preferentially targets stalled promoters of coding and noncoding transcripts. Genome Res (2010) 1.63
Distinct genetic alterations in colorectal cancer. PLoS One (2010) 1.56
Improved BLAST searches using longer words for protein seeding. Bioinformatics (2007) 1.51
Mutation in CEP290 discovered for cat model of human retinal degeneration. J Hered (2007) 1.46
Genetic differences detected by comparative genomic hybridization in head and neck squamous cell carcinomas from different tumor sites: construction of oncogenetic trees for tumor progression. Genes Chromosomes Cancer (2002) 1.45
HAX1 mutations causing severe congenital neuropenia and neurological disease lead to cerebral microstructural abnormalities documented by quantitative MRI. Am J Med Genet A (2010) 1.40
Squamous papilloma: case report and review of literature. Int J Oral Sci (2010) 1.40
Probabilistic inference of viral quasispecies subject to recombination. J Comput Biol (2013) 1.40
Loss-of-function mutations in the IL-21 receptor gene cause a primary immunodeficiency syndrome. J Exp Med (2013) 1.39
Digenic inheritance in medical genetics. J Med Genet (2013) 1.38
Quantifying cancer progression with conjunctive Bayesian networks. Bioinformatics (2009) 1.37
Mutations in STAT3 and diagnostic guidelines for hyper-IgE syndrome. J Allergy Clin Immunol (2010) 1.36
A homozygous single-base deletion in MLPH causes the dilute coat color phenotype in the domestic cat. Genomics (2006) 1.35
The BEACH is hot: a LYST of emerging roles for BEACH-domain containing proteins in human disease. Traffic (2013) 1.35
A quantitative and dynamic model for plant stem cell regulation. PLoS One (2008) 1.32
Reduced incidence of hip fracture in the Old Order Amish. J Bone Miner Res (2003) 1.29
Identification of a homozygous deletion in the AP3B1 gene causing Hermansky-Pudlak syndrome, type 2. Blood (2006) 1.28
Involvement of novel human immunodeficiency virus type 1 reverse transcriptase mutations in the regulation of resistance to nucleoside inhibitors. J Virol (2006) 1.28
Anabaptist genealogy database. Am J Med Genet C Semin Med Genet (2003) 1.28
Mutant deoxynucleotide carrier is associated with congenital microcephaly. Nat Genet (2002) 1.25
Amnionless function is required for cubilin brush-border expression and intrinsic factor-cobalamin (vitamin B12) absorption in vivo. Blood (2005) 1.25
An approximately 140-kb deletion associated with feline spinal muscular atrophy implies an essential LIX1 function for motor neuron survival. Genome Res (2006) 1.25
Analysis of HIV-1 expression level and sense of transcription by high-throughput sequencing of the infected cell. J Virol (2011) 1.25
Four independent mutations in the feline fibroblast growth factor 5 gene determine the long-haired phenotype in domestic cats. J Hered (2007) 1.25
Novel gene acquisition on carnivore Y chromosomes. PLoS Genet (2006) 1.23
A 1.5-Mb-resolution radiation hybrid map of the cat genome and comparative analysis with the canine and human genomes. Genomics (2006) 1.23
BitPhylogeny: a probabilistic framework for reconstructing intra-tumor phylogenies. Genome Biol (2015) 1.22
The hyper IgE syndrome and mutations in TYK2. Immunity (2007) 1.21
A genome-wide scan for primary open-angle glaucoma (POAG): the Barbados Family Study of Open-Angle Glaucoma. Hum Genet (2003) 1.21
The temporal order of genetic and pathway alterations in tumorigenesis. PLoS One (2011) 1.20
Does having children extend life span? A genealogical study of parity and longevity in the Amish. J Gerontol A Biol Sci Med Sci (2006) 1.18
Estimating cancer survival and clinical outcome based on genetic tumor progression scores. Bioinformatics (2005) 1.18
A rhesus macaque radiation hybrid map and comparative analysis with the human genome. Genomics (2005) 1.17
Improved prediction of response to antiretroviral combination therapy using the genetic barrier to drug resistance. Antivir Ther (2007) 1.17
Read length versus depth of coverage for viral quasispecies reconstruction. PLoS One (2012) 1.16
A microsatellite polymorphism in intron 2 of human Toll-like receptor 2 gene: functional implications and racial differences. FEMS Immunol Med Microbiol (2004) 1.14
A high-resolution cat radiation hybrid and integrated FISH mapping resource for phylogenomic studies across Felidae. Genomics (2008) 1.13
Susceptibility to oral cancer by genetic polymorphisms at CYP1A1, GSTM1 and GSTT1 loci among Indians: tobacco exposure as a risk modulator. Carcinogenesis (2007) 1.12
Stable karyotypes in epithelial cancer cell lines despite high rates of ongoing structural and numerical chromosomal instability. Neoplasia (2002) 1.12
An autosomal genetic linkage map of the domestic cat, Felis silvestris catus. Genomics (2008) 1.10
Tenofovir resistance and resensitization. Antimicrob Agents Chemother (2003) 1.10
Single-cell genetic analysis of ductal carcinoma in situ and invasive breast cancer reveals enormous tumor heterogeneity yet conserved genomic imbalances and gain of MYC during progression. Am J Pathol (2012) 1.09
Clinical and positron emission tomography of Parkinson's disease caused by LRRK2. Ann Neurol (2005) 1.09
Predicting the response to combination antiretroviral therapy: retrospective validation of geno2pheno-THEO on a large clinical database. J Infect Dis (2009) 1.07
Idiopathic gingival fibromatosis: case report and its management. Int J Dent (2010) 1.06
Next-generation sequencing of HIV-1 RNA genomes: determination of error rates and minimizing artificial recombination. PLoS One (2013) 1.04
Genomic aberrations in an African American colorectal cancer cohort reveals a MSI-specific profile and chromosome X amplification in male patients. PLoS One (2012) 1.02
Linkage of autosomal-dominant common variable immunodeficiency to chromosome 4q. Eur J Hum Genet (2006) 1.02
Competition-colonization dynamics in an RNA virus. Proc Natl Acad Sci U S A (2010) 1.01
Lung lesions in children with Crohn's disease presenting as nonresolving pneumonias and response to infliximab therapy. Pediatrics (2006) 1.01
Cell selection as driving force in lung and colon carcinogenesis. Cancer Res (2010) 1.01
Quantitative immunohistochemical analysis reveals association between sodium iodide symporter and estrogen receptor expression in breast cancer. PLoS One (2013) 1.00
PedHunter 2.0 and its usage to characterize the founder structure of the Old Order Amish of Lancaster County. BMC Med Genet (2010) 1.00
PSEUDOMARKER: a powerful program for joint linkage and/or linkage disequilibrium analysis on mixtures of singletons and related individuals. Hum Hered (2011) 0.99
Phylogenetic analysis of multiprobe fluorescence in situ hybridization data from tumor cell populations. Bioinformatics (2013) 0.99
Tumor classification using phylogenetic methods on expression data. J Theor Biol (2004) 0.99
The chromatin-binding protein HMGN1 regulates the expression of methyl CpG-binding protein 2 (MECP2) and affects the behavior of mice. J Biol Chem (2011) 0.98
Genetic alterations in caspase-10 may be causative or protective in autoimmune lymphoproliferative syndrome. Hum Genet (2006) 0.97
Construction of oncogenetic tree models reveals multiple pathways of oral cancer progression. Int J Cancer (2009) 0.97
Investigations of the Y chromosome, male founder structure and YSTR mutation rates in the Old Order Amish. Hum Hered (2007) 0.96
Accurate single nucleotide variant detection in viral populations by combining probabilistic clustering with a statistical test of strand bias. BMC Genomics (2013) 0.96
Defining and mapping mammalian coat pattern genes: multiple genomic regions implicated in domestic cat stripes and spots. Genetics (2009) 0.96
Fluorescence in situ hybridization markers for prediction of cervical lymph node metastases. Am J Pathol (2009) 0.95
Kinetic, energetic, and mechanical differences between dark-state rhodopsin and opsin. Structure (2013) 0.95